SCHEMBL6574714

SCHEMBL6574714

CCCN(CCC)C(=O)c1cc(C)cc(C(=O)N[C@@H](Cc2cc(F)cc(F)c2)C[C@H](O)CO)c1

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.62
BACE2 Q9Y5Z0 5/20 0.62
CTSD P07339 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6043858 0.91 BACE1 (0.62) BACE1BACE2CTSD
SCHEMBL13929735 0.87 BACE1 (0.59) BACE1BACE2CTSD
SCHEMBL13930233 0.86 BACE1 (0.57) BACE1BACE2CTSD
SCHEMBL3348915 0.85 BACE1 (0.75) BACE1BACE2CTSD
SCHEMBL3349982 0.82 BACE1 (0.74) BACE1BACE2CTSD
SCHEMBL5363946 0.82 BACE1 (0.74) BACE1BACE2CTSD
SCHEMBL13930108 0.81 BACE1 (0.61) BACE1BACE2CTSD
SCHEMBL3352035 0.81 BACE1 (0.72) BACE1BACE2CTSD
SCHEMBL3354515 0.81 BACE1 (0.80) BACE1BACE2CTSD
SCHEMBL5371352 0.81 BACE1 (0.74) BACE1BACE2CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453792-A1 AMINE 1,2- AND 1,3-DIOL COMPOUNDS AND THEIR USE FOR TREATMENT OF ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-09-08 EP disclosed
WO-2003043975-A1 AMINE 1,2- AND 1,3-DIOL COMPOUNDS AND THEIR USE FOR TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2003-05-30 WO disclosed